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In previous studies, the Beaudette strain of coronavirus infectious bronchitis virus (IBV) was adapted
from chicken embryo to Vero, a monkey kidney cell line, by serial propagation for 65 passages. To
characterize the susceptibility of other human and animal cells to IBV, 15 human and animal cell lines
were infected with the Vero-adapted IBV and productive infection was observed in four human cell
lines: H1299, HepG2, Hep3B and Huh7. In other cell lines, the virus cannot be propagated beyond
passage 5. Interestingly, cellular furin abundance in ﬁve human cell lines was shown to be strongly
correlated with productive IBV infection. Cleavage of IBV spike protein by furin may contribute to the
productive IBV infection in these cells. The ﬁndings that IBV could productively infect multiple human
and animal cells of diverse tissue and organ origins would provide a useful system for studying the
pathogenesis of coronavirus.
& 2012 Elsevier Inc. All rights reserved.Introduction
Entry of viruses into host cells by crossing the plasma membrane
is an essential step for successful viral replication. This process is
initially mediated by the interaction of a viral protein with its
corresponding host cell receptor(s). This interaction is therefore
one of the prime determinants for the host cell speciﬁcity of a virus.
Cellular receptors identiﬁed for coronavirus, important pathogens of
human and many other animal species, include aminopeptidase N
(APN) for alphacoronaviruses transmissible gastroenteritis virus
(TGEV), human coronavirus (HCoV) 229E, canine coronavirus (CCoV)
and feline infectious peritonitis virus (FIPV) (Delmas et al., 1992;
Tresnan et al., 1996; Yeager et al., 1992), the carcinoembryonic
antigen–cell adhesion molecular (CEACAM) for mouse hepatitis virus
(MHV) (Coutelier et al., 1994; Dveksler et al., 1991; Godfraind et al.,
1995; Williams et al., 1991), and angiotensin-converting enzyme 2
(ACE2) and CD209L for severe acute respiratory syndrome corona-
virus (SARS-CoV) and HCoV-NL63 (Hofmann et al., 2005; Jeffers et al.,
2004; Li et al., 2003). CD209L was initially identiﬁed as an attachment
factor for human immunodeﬁciency virus (Curtis et al., 1992;
Geijtenbeek et al., 2000), but was subsequently found to be a co-
receptor for hepatitis C virus (Pohlmann et al., 2003), cytomegalovirusll rights reserved.(Halary et al., 2002), dengue virus (Tassaneetrithep et al., 2003) and
SARS-CoV (Jeffers et al., 2004).
Coronavirus infectious bronchitis virus (IBV), a prototype
coronavirus, is the etiological agent of infectious bronchitis which
impairs the respiratory and urogenital tracts of chicken
(Cavanagh, 2007). The receptor(s) for IBV in its native or adapted
host cells remains unknown, although IBV might use APN as a
receptor in vitro (Miguel et al., 2002). In addition, the widely
distributed sialic acid was suggested to be important for the
primary attachment of IBV to host cells (Winter et al., 2006). In a
more recent paper, DC-SIGN-like lectins, including L-SIGN, were
shown to be able to increase susceptibility to infection by IBV in
otherwise refractory cells (Zhang et al., 2012).
In a recent study, furin was shown to be responsible for pro-
teolytic activation of S protein at a novel RRRR690/S motif in the S2
region (Yamada and Liu, 2009). This cellular proprotein convertase is
a calcium-dependent serine protease that circulates between trans-
Golgi network (TGN), plasma membrane, and early endosome by
association with exocytic and endocytic pathways (Bosshart et al.,
1994; Molloy et al., 1994). It cleaves a wide variety of protein
precursors after the C-terminal arginine (R) residue in the preferred
consensus motif (RXR(K)R/R (K, lysine; X, any amino acid). Introduc-
tion of mutations into the RRRR690/S motif and use of speciﬁc furin
inhibitors demonstrated that furin may play an important role in
furin-dependent entry, cell–cell fusion and infectivity of IBV in
cultured cells (Yamada and Liu, 2009). Similar observations were
also reported by Belouzard et al. (2009).
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F.P.L. Tay et al. / Virology 433 (2012) 421–430422Coronaviruses generally have a limited host range. However,
recent evidence showed that several coronaviruses could break
the host barrier and become zoonotic. For example, the novel
SARS-CoV was found to cross host species from animal to human
(Guan et al., 2003). HCoV-OC43 could infect cells from a large
number of mammalian species, although the virus was propa-
gated exclusively in suckling mouse brains (Butler et al., 2006). To
study the mechanisms underlying the host cell speciﬁcity and
susceptibility to coronavirus and coronavirus–host interactions,
the Beaudette strain of IBV was adapted from chicken embryo to a
monkey kidney cell line, Vero, by continuous propagation for 65
passages (Shen et al., 2003, 2004). This adaptation was accom-
panied by mutations in the spike (S) protein (Fang et al., 2005,
2007). In this study, infection of 15 cell lines of different species
and tissue origins with the Vero cell-adapted IBV shows that four
out of the 15 cell lines were able to support continuous and
productive IBV infection with high efﬁciency. Meanwhile, strong
correction between cellular furin abundance and productive IBV
infection was found in ﬁve human cell lines infected with IBV.N
-actin
50
Fig. 1. Infection of 15 human and animal cell lines with IBV. (a)Western blot analysis
of the expression of IBV N protein in IBV-infected HCT116, H1299, HepG2, Huh7 and
Hep3B cells. Cells were infected with passages 1–3 of IBV and harvested at 24 h post-
infection. Cell lysates were prepared and separated on SDS-10% polyacrylamide gels.
The expression of IBV N protein was analyzed byWestern blot with anti-N antibodies,
after the proteins were separated by SDS-PAGE. The membrane was also probed with
anti-actin monoclonal antibody as a loading control. (b) Western blot analysis of the
expression of IBV N protein in IBV-infected DLD-1, CHO, MRC-5, DLD-1A and A549
cells. Cells were infected with passages 1–3 of IBV and harvested at 24 h post-
infection. Cell lysates were prepared and separated on SDS-10% polyacrylamide gels.
The expression of IBV N protein was analyzed byWestern blot with anti-N antibodies,
after the proteins were separated by SDS-PAGE. The membrane was also probed with
anti-actin monoclonal antibody as a loading control. (c) Western blot analysis of the
expression of IBV N protein in IBV-infected HeLa, 293T, Cos-7, U937 and BHK cells.
Cells were infected with passages 1–3 of IBV and harvested at 24 h post-infection.
Cell lysates were prepared and separated on SDS-10% polyacrylamide gels. The
expression of IBV N protein was analyzed by Western blot with anti-N antibodies,
after the proteins were separated by SDS-PAGE. The membrane was also probed with
anti-actin monoclonal antibody as a loading control.Results
Susceptibility of different human and animal cell lines
to Vero-adapted IBV
The susceptibility of 15 human and animal cell lines to IBV
infection was tested by infecting cells with the 65th passage (p65)
of Vero-adapted IBV. The tissue and species origins of these cell
lines are listed in Table 1. Based on the preliminary observations
from pilot tests, the susceptibility of these cells to IBV could be
divided into two groups, the more susceptible and the more
resistant groups. The more susceptible cell lines, including H1299,
Huh7, HepG2, Hep3B and HCT116, were infected with IBV at a
multiplicity of infection of approximately 0.1 and harvested at 0,
12, 16, 24, 36 and 48 h post-infection, respectively. The more
resistant cells, including A549, MRC-5, DLD-1, DLD-1Amix, CHO,
U937, HeLa, BHK-21, 293T, and Cos-7, were infected with IBV at a
multiplicity of infection of approximately 0.3, a higher MOI to
ensure successful infection of these cells, and harvested at the
same time points as the former group.
The results showed that almost all cell lines tested could be
infected by virus stocks prepared from IBV-infected Vero cells in
passage 1. These cells were then continuously infected with the
freezing/thawing preparations of IBV from the same cell linesTable 1
Continuous propagation of IBV in 16 susceptible cell lines.
Cell
line
Tissue Organism Productive
infectiona
H1299 Lung Human Yes
A549 Lung Human No
MRC-5 Lung Human No
Huh7 Liver Human Yes
HepG2 Liver Human Yes
Hep3B Liver Human Yes
HCT116 Colorectal Human Yes/no
DLD-1 Colorectal Human No
DLD-1A Colorectal Human No
Vero Kidney Monkey Yes
BHK Kidney Hamster No
293T Kidney Human No
Cos-7 Kidney Monkey No
CHO Ovarian Hamster No
HeLa Cervical Human No
U937 Blood Human No
a Continuous propagation of IBV up to at least 20 passages.infected with IBV. IBV was found to be able to propagate
efﬁciently to at least passage 20 (p20) only in four lines derived
from human cancer cells, i.e., H1299, Huh7, Hep3B and HepG2
(Table 1). In other cell lines, viral infectivity was found to be lost
in passages 2–5 (Table 1). Fig. 1a–c shows the expression of IBV
nucloecapsid (N) protein in the 15 cell lines infected by passages
1–3 of IBV, which were harvested at 24 h post-infection. One
exception is HCT116 cell line, in which productive infection with
low efﬁciency was observed after 20 passages (Table 1).
Characterization of viral structural protein expression and syncytium
formation in productive IBV infection of six human and animal cell
lines
The expression kinetics of IBV structural proteins, S, mem-
brane (M) and N, in H1299, Huh7, Hep3B, HepG2 and HCT116
cells were analyzed by Western blot with polyclonal antibodies.
As a positive control, Vero cells were ﬁrst infected with IBV at a
multiplicity of infection of approximately 1 and analyzed. As
shown in Fig. 2a, analysis of IBV-infected Vero cells with anti-S
antibodies detected the full-length glycosylated (Sn), the full-
length unglycosylated (S) and the S1/S2 cleavage forms of the
protein from 12 h post-infection. Analysis of the same cell lysates
with anti-N antibodies detected the full-length N protein (N) from
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Fig. 2. Viral structural protein expression and syncytium formation in productive IBV infection of ﬁve human and animal cell lines. (a) Western blot analysis of the expression of
IBV S, M and N proteins in IBV-infected Vero cells. Vero cells were infected with IBV at a multiplicity of infection of approximately 1 and harvested at 0, 4, 8, 12 and 24 hours post-
infection, respectively. Cell lysates were prepared and separated on SDS-10% polyacrylamide gels. The expression of IBV S, N and M proteins was analyzed by Western blot with
anti-S, -N and -M antibodies, respectively, after the proteins were separated by SDS-PAGE. The full-length glycosylated (S*), the full-length unglycosylated (S) and the S1/S2
cleavage forms of the S protein are labeled. Also indicated are the full-length N protein (N) and several more-rapidly-migrating bands (N^). Both glycosylated and unglycosylated M
protein were labeled as M. The membrane was also probed with anti-actin monoclonal antibody as a loading control. (b) Analysis of IBV infection in H1299, Huh7, HepG2, Hep3B
and HCT116. Cells were infected with IBV and harvested at 0, 12, 16, 24, 36, and 48 h post-transfection. Cell lysates were prepared and separated on SDS-10% polyacrylamide gels.
The expression of IBV S and N proteins was analyzed byWestern blot with anti-S and -N antibodies, respectively, after proteins were separated by SDS-PAGE. Themembranes were
also probed with anti-actin monoclonal antibody as loading controls. (c) Cytopathic effect of Vero, Huh7, H1299, Hep3B, HepG2 and HCT116 cells infected with the Vero-adapted
IBV. Cells were infected with IBV at a multiplicity of infection of approximately 0.1 and observed with phase-contrast microscopy at 12–24 h post-infection.
F.P.L. Tay et al. / Virology 433 (2012) 421–430 4238 h post-infection, in addition to several more-rapidly-migrating
bands (N^) (Fig. 2a) representing either cleavage or premature
termination products of N protein (Li et al., 2005). The same
lysates were also probed with anti-M antibodies, showing the
expression of M protein from 12 h post-infection (Fig. 2a). As both
M and S showed similar expression kinetics, analysis of only S and
N proteins was conducted in other IBV-infected cells in the
subsequent studies.
Efﬁcient IBV infection, as observed by Western blot analysis
with anti-S and anti-N antibodies, was detected in four human cell
lines, H1299, Huh7, HepG2 and Hep3B infected with the Vero-
adapted IBV (Fig. 2b). Consistent with the weak productive infection
observed during continuous passages of IBV in HCT116 cells, the
accumulation of S and N proteins was much slower in this cell line
over the time-course, compared to that in the other cell lines
(Fig. 2b). It was also noted that the patterns of S protein cleavage
and processing were slightly different from cell line to cell line
(Fig. 2b). As these patterns were not consistently observed in a
given cell line in repeated experiments (data not shown), it is
unlikely that they may reﬂect differences in post-translational
modiﬁcation and processing of the protein in a given cell line.
The cytopathic effect (CPE) caused by IBV infection in these
cells was also visually examined by microscopy at 12–24 h post-
infection. Similar to that in Vero cells, infection of H1299, Huh7,
HepG2 and Hep3B cells with IBV generated giant syncytia at
12–24 h post-infection, leading to the destruction of the entire
monolayers and death of the infected cells afterwards (Fig. 2c).
However, syncytium formation was not observed in HCT116 cells(Fig. 2c). Instead, the infected cells were rounded up and lysed
eventually (Fig. 2c). As productive infection was consistently
observed in these cell lines, we would refer the infection of IBV
in these cell lines (as well as in Vero cells) as productive IBV
infection subsequently in this study.Growth properties and stability of IBV in H1299, Huh7 and
HCT116 cells
The growth kinetics of p1, p5 and p20 viruses collected from
IBV-infected H1299 and Huh7 cells were characterized. As IBV
infection of the three cell lines of human hepatoma origin, Huh7,
HepG2 and Hep3B cells, showed similar kinetics in terms of
growth and protein synthesis, only Huh7 cells were chosen for
this study. Analysis of the growth kinetics of p1, p5, and p20 from
H1299 and Huh7 showed similar growth kinetics as in Vero cells
(Fig. 3a–c). Viruses reached their peak titer at 16–24 h post-
infection and declined afterwards (Fig. 3b and c).
These growth curves indicated that the infectivity of Vero-
adapted IBV did not change much during propagation in human
cells, suggesting that the virus readily infected human cells without
requirement for further adaptation. To conﬁrm this possibility, the
genetic stability of IBV in H1299 and Huh7 cells was tested by
sequencing the S gene from plaque-puriﬁed as well as unpuriﬁed p1,
p5 and p20 passages. Only one silent mutation from ATT (Ilu) to ATC
(Ilu) at the nucleotide position 23565 was found in the S2 region of
two isolates from Huh7-p5. The occurrence of rare and inconsistent
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Fig. 3. Growth curves of passages 1, 5 and 20 of IBV in H1299 and Huh7 cells. (a) Vero cells were infected with IBV and harvested at 0, 4, 8, 12, 16, 24 and 36 h post-
infection, respectively. Cells were lysed by freezing and thawing three time and viral titers were determined by TCID50 assay on Vero cells. (b) H1299 cells were infected
with H1299-p1, H1299-p5 and H1299-p20, respectively, and harvested at 0, 6, 10, 16, 24 and 36 h post-infection, respectively. Cells were lysed by freezing and thawing
three times and viral titers were determined by TCID50 assay on Vero cells. (c) Huh7 cells were infected with Huh7-p1, Huh7-p5 and Huh7-p20, respectively, and
harvested at 0, 6, 10, 16, 24 and 36 h post-infection. Cells were lysed by freezing and thawing three times and viral titers were determined by TCID50 assay on Vero cells.
F.P.L. Tay et al. / Virology 433 (2012) 421–430424mutations in the S gene conﬁrms that the Vero-adapted IBV is
genetically stable during passaging in human cell lines.
Correlation between productive IBV infection and cellular furin
abundance in Huh7, H1299, HeLa, A549 and 293T cells
The observation that IBV could infect most cell lines tested in
passage 1 but lost infectivity in subsequent passages in some cell
lines suggests that the cellular restriction point(s) may exist at some
late stages of the viral life cycle during primary infection and early
stages during secondary infection, probably at the release of progeny
viruses and spread of infection to neighboring cells. In a previous
study, a novel furin site is identiﬁed in the IBV S protein that is
essential for furin-dependent entry, syncytium formation and infec-
tivity of IBV in cultured cells (Yamada and Liu, 2009). It prompted us
to examine the cellular content of furin in these cells. Western
blotting analysis of Huh7, H1299, HeLa, 293T and A549 cells showed
differential expression of furin (Fig. 4a). Quantiﬁcation of the
corresponding bands by densitometry showed that the relative furin
abundances in these ﬁve cell lines are 293T (0.04), A549 (0.18), HeLa
(0.29), H1299 (0.56) and Huh7 (treated as 1) (Fig. 4a). Due to the lack
of speciﬁcity, the furin antibody used failed to detect the protein in
Vero and other cells of animal origin (data not shown).
Interestingly, the two cell lines, Huh7 and H1299, with high
levels of furin expression are highly permissive to IBV and support
productive IBV infection. To study further the infection kinetics of
IBV infection and to compare the viral infectivity in these cells, the
same number of cells (2106) was plated. After incubation for
14 h, cells were infected with IBV-Luc at a multiplicity of infection
of approximately 2, harvested at 24 h post-infection, and the
luciferase activities were measured (Shen et al., 2009). The highest
readings were consistently obtained from IBV-infected Huh7 cells,
and were considered as 100% infection efﬁciency for each passageof IBV in this cell line, and the readings in other cells were shown as
percentages of that in Huh7 cells (Fig. 4b). Compared to IBV-
infected Huh7 cells, the percentages of the relative luciferase
activity (relative IBV infectivity) in IBV-infected H1299, 293T, HeLa
and A549 cells are 68.55, 19.32, 9.15 and 0.88%, respectively, at
passage 1 (Fig. 4b). At passage 2, the percentages were reduced to
26.29, 0.12, 0.46 and 0%, respectively, in IBV-infected H1299, 293T,
HeLa and A549 cells (Fig. 4b). At passage 5, the percentage in H1299
cells is 32.94%, and no infection was observed in the other three cell
lines (Fig. 4b). Based on the luciferase reading, IBV replication in
H1299 cells at passages 2 and 5 appeared to be much reduced,
compared to that in passage 1. However, no obvious reduction in
IBV replication was observed when the virus was continuously
propagated in this cell line, based on the growth curves shown in
Fig. 3b. The reason for this discrepancy is currently unclear, but it
may reﬂect the intrinsic differences of the two assays, that is, the
luciferase assay is to measure the viral replication and protein
synthesis in the cell and the growth curve is to measure the
production of infectious virus particles.
The furin abundance in other three human cell lines, Hep3B,
HepG2 and HCT116, with varying susceptibilities to IBV was
analyzed by Western blot. Once again, differential expression of
furin in these cells was observed. Compared with the furin level in
Huh7 (treated as 1), the relative furin abundances in these cells
are Hep3B (0.6), HCT116 (0.13) and HepG2 (0.28), as determined
by densitometry (Fig. 4c). The data largely correlate with the
permissiveness of these cell lines to productive IBV infection, with
HepG2 cells as one exception, which was shown to have an
intermediate level of furin. The reason why HepG2 cells could
support efﬁcient productive IBV infection but are with a relatively
low furin abundance is currently unclear. It would point to the
involvement of multiple host cell factors in either restriction or
promotion of IBV infection and is worthy of further studies.
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Fig. 4. Correlation between cellular furin content and productive IBV infection in ﬁve human cell lines. (a) Western blot analysis of the furin abundance in 293 T, A549, H1299, HeLa
and Huh7 cells. Total lysates were prepared and separated on SDS-12% polyacrylamide gels. The expression of furin was analyzed by Western blot with anti-furin antibodies. The
furin band (furin) and an unknown band (*) are indicated. The membrane was also probed with anti-actin monoclonal antibody as a loading control. The relative furin abundance in
these cells is shown as the fraction of the furin abundance in Huh7 cells, which was arbitrarily deﬁned as 1. (b) Productive IBV infection in 293T, A549, H1299, HeLa and Huh7 cells.
2106 cells in duplicate were plated and infected with IBV-Luc at a multiplicity of infection of approximately 2. Cells were harvested at 24 h post-infection and virus stocks were
prepared from one set of cells by freezing and thawing and used to infect fresh cells. The luciferase activities were measured from the other set of cells and the readings from IBV-
infected Huh7 cells were considered as 100% infection efﬁciency for each passage. The readings in other cells were shown as percentages of that in Huh7 cells. (c) Western blot
analysis of the furin abundance in Hep3B, HCT116, HepG2 and Huh7 cells. Total lysates were prepared and separated on SDS-12% polyacrylamide gels. The expression of furin was
analyzed by Western blot with anti-furin antibodies. The furin band (furin) and an unknown band (*) are indicated. The membrane was also probed with anti-actin monoclonal
antibody as a loading control. The relative furin abundance in these cells is shown as the fraction of the furin abundance in Huh7 cells, which was arbitrarily deﬁned as 1.
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expression in H1299 cells
Knockdown of furin by siRNA in both Huh7 and H1299 cells
was then carried out to test further if productive IBV infection is
correlated with the furin abundance in each cell line. As shown in
Fig. 5a, introduction of siRNA duplexes targeting furin into H1299
cells signiﬁcantly reduced the furin expression at the protein
level. However, only a marginal effect was achieved in Huh7 cells
(Fig. 5a), probably reﬂecting the poorer transfection efﬁciency in
this cell line. Infection of these cells with IBV at a multiplicity of
infection of approximately 1 showed formation of much smaller
sycyntia in furin-knockdown H1299 cells at 20 h post-infection,
compared to the control cells transfected with siRNA targeting
EGFP (Fig. 5b). Continuous propagation of IBV prepared from the
same set of furin-knockdown and control cells led to a loss of viral
infectivity from the second passage onward in furin-knockdown
H1299 cells, but not in H1299 cells treated with siEGFP and Huh7
cells treated with siEGFP and siFurin, respectively (Fig. 5c). More S
protein was expressed in Huh7 cells transfected with siEGFP than
did in siFurin-transfected cells, probably due to their relative
higher furin abundance, which would in turn enhance viral
infection (Fig. 5c). Interestingly, higher expression of IBV S protein
was detected in passage 2 of IBV-infected Huh7 cells treated with
either siFurin or siEGFP than that in passage 1 (Fig. 5c), correlating
with the highest expression level of furin in this cell line. Taken
together, these results conﬁrm that the abundant expression offurin is one of the factors that support productive IBV infection in
cultured cells.
Enhancement of productive IBV infection by knockin of furin in A549
cells
Five stable furin-knockin clones with different levels of furin
expression were then selected from A549 cells (Fig. 6a). It was
noted that stable clones with higher levels (clones 1, 3 and 5) of
furin expression tended to round up and die soon after forming
monolayers (data not shown), probably due to the harmful effect
of high furin expression level in this cell line. Infection of these
clones with IBV at passage 1 showed much more efﬁcient viral
infection, compared to that in wild type A549 cells (Fig. 6a). As
shown in Fig. 6b, the formation of large syncytia at 24 h post-
infection was seen in IBV-infected clones 4 and 5 at passage 1
(Fig. 6b). However, many rounded-up and dead cells were
observed in IBV-infected clone 5 at 24 h post-infection (Fig. 6b).
The same phenomenon was observed in other furin-knockin
clones with an intermediate to high level of furin expression.
Continuous propagation of IBV in clones 4 and 5 was then
carried out, showing efﬁcient infection in wild type and the two
stable clones at passage 1 (Fig. 6b and c). However, the infectivity
was gradually attenuated in the subsequent passages and that the
virus could be propagated up to passage 4 only in clone 4, but not
in clone 5 due to massive death of the infected cells (Fig. 6b and
c). IBV infection of clone 4 tends to show restricted CPE with the
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(b) Effect of furin-knockdown on syncytium formation in IBV-infected H1299 cells. H1299 cells were transfected with siRNA duplexes targeting either EGFP or Furin, and
infected with IBV at a multiplicity of infection of approximately 1 at 24 h post-transfection. Cells were observed under microscopy at 24 h post-infection. The cells were
then ﬁxed and stained with anti-IBV S antibodies. (c) Effect of furin-knockdown on productive IBV infection in H1299 and Huh7 cells. H1299 and Huh7 cells were
transfected with siRNA duplexes targeting either EGFP or Furin, and infected with IBV at a multiplicity of infection of approximately 1 at 24 h post-transfection. Total cell
lysates prepared from p1 and p2 infected cells were separated on SDS-12% polyacrylamide gels and analyzed by Western blot with ant-IBV S antibodies. The membrane
was also probed with anti-actin monoclonal antibody as a loading control.
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(Fig. 6b). This result reveals the harmful effect of higher furin
expression level and indicates that additional factor(s) may be
required for efﬁcient productive infection of IBV in this cell line.
The effect of furin abundance on IBV infection was further
studied by transfection of furin into 293T cells, followed by
infection of the transfected cells with IBV at a multiplicity of
infection of approximately 1. As shown in Fig. 6d, overexpression
of furin in 293T cells resulted in the detection of approximately
2-fold more N protein (Fig. 6d). Titration of the virus particles
released to the culture media showed 4.2-fold more infectious
virus particles were released from cells overexpressing furin.
Analysis of IBV S protein cleavage at the two conﬁrmed furin-
cleavage sites in Huh7, H1299, HeLa, A549 and 293T cells
After demonstrating the relationship between the cellular
furin abundance and the productive IBV infection in Huh7,
H1299, HeLa, A549 and 293T cells, the cleavage efﬁciency of IBV
S protein by furin at the two identiﬁed furin sites in these cell
lines was then studied by transfection with appropriate S con-
structs and infection with IBV, respectively. First, Huh7, H1299,
HeLa, A549 and 293T cells were transfected with S(1–789)Fc
construct (Fig. 7a) (Yamada and Liu, 2009), and analyzed by
Western blot with human IgG. Expression of S(1–789)Fc inH1299 and Huh7 led to efﬁcient cleavage of S-Fc fusion protein
at both R537/S (cl-1C) and R690/S (cl-2C) positions (Fig. 7b). Much
weaker cleavage could be detectable in HeLa after prolong
exposure of the gel (data not shown). No obvious cleavage of
the fusion protein at the two positions was detected when the
construct was expressed in 293T and A549 cells (Fig. 7b), reveal-
ing the correlation between the low furin abundance and the lack
of S protein proteolysis in these cells.
Huh7, HeLa, A549 and Vero cells were then infected with a
recombinant IBV expressing a Flag-tagged S protein (IBVS-
Flag539) (Fig. 7a) (Yamada and Liu, 2009). In addition to the
detection of the full-length S protein (S-Flag539), products
derived from single cleavage at R537/S (cl-1C) and R690/S (cl-2N)
sites as well as dual cleavage (cl-dual) were clearly detected in
Huh7 and Vero cells infected with the recombinant virus (Fig. 7c).
The percentages of the three cleavage products were 15, 43 and
32%, respectively in Vero cells, and 14, 43 and 34%, respectively, in
Huh7 cells (Fig. 7c). The same set of cleavage products was also
detected, although with much reduced efﬁciency, in HeLa cells
infected with the recombinant IBV (Fig. 7c). The percentages of
the three cleavage products were 16, 22 and 8%, respectively, in
this cell line (Fig. 7c). However, no cleavage bands were detected
in A549 cells infected with the same virus (Fig. 7c). Taken
together, these results suggest that the correlation between the
cellular furin abundance and the productive IBV infection in
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cleavage mediated by furin. As cleavage of IBV S protein at the
ﬁrst furin site (R537/S) was shown to be nonessential for the
replication and infectivity of IBV in cultured cells (Yamada and
Liu, 2009; Yamada et al., 2009), acquisition of the second furin site
(R690/S) during adaptation of IBV Beaudette strain from chicken
embryo to cell culture system may be essential for the adaptation
process.Discussion
Coronavirus is generally believed to have a narrow range of
host speciﬁcity. For example, chicken is the only natural host for
IBV, although IBV was also isolated from pheasants as well
(Gough et al., 1996). Clinical and ﬁeld isolates of IBV can only
be propagated either in embryonated chicken eggs or transiently
in primary chicken embryo kidney cells. IBV Beaudette-42 and
Holte strains could grow in BHK-21 cell line (Otsuki et al., 1979),
and the Beaudette strain of IBV from chicken embryo was adapted
to Vero cells (Shen et al., 2003, 2004). More recently, IBV wasshown to infect HeLa cells depending on the status of the cells
(Chen et al., 2007). However, the susceptibility of other cell lines
to IBV has not been documented. In this study, cell lines of diverse
species and tissue origins were shown to be susceptible to the
Vero-adapted IBV. The virus was efﬁciently propagated in four
human cell lines, including H1299, HepG2, Hep3B and Huh7, for
at least 20 passages. Among the four cell lines, HepG2, Hep3B, and
Huh7 cell lines are derived from human hepatoma, and H1299
cells are human cancer cells of lung origins, respectively. Con-
tinuous propagation of the Vero-adapted IBV in human cells
showed no further accumulation of mutations in the S protein.
The fact that IBV has gained the ability to infect human and other
animal cells once adapted to Vero cells suggests that adaptation
of IBV to a monkey kidney cell line may allow the virus to cross
not only species but also tissue barriers.
The presence of cellular receptor(s) in a particular cell line is a
pre-requisite for the establishment of successful infection by a
virus. Although the cellular receptor(s) for IBV is yet to be ﬁrmly
established, association of cell-surface sialic acid and a low-pH
environment were reported to be required for IBV entry (Chu
et al., 2006; Winter et al., 2006, 2008). The observation that most
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in passage 1 suggests that the Vero-adapted IBV is able to enter
and replicate efﬁciently in these cells, but cannot support pro-
ductive IBV infection, pointing to the possibility that additional
host factors are required to enhance the infectivity and to
promote productive IBV infection in these cells.
Another important host cell restriction point may be at the
release of progeny viruses from initially infected cells and spread
of the primary infection to the neighboring cells. Generally, IBV is
not efﬁciently released to the culture medium even in highly
permissive cells. When most cell lines were initially infected with
Vero-adapted IBV, relatively efﬁcient infection was observed.
During subsequent passages of the virus in the more resistant
cells, however, the viral infectivity was gradually attenuated and
totally lost after less than ﬁve passages. Slightly less efﬁcient IBV
infection was even observed in H1299 cells transfected with
siEGFP in passage 2, although the same treated H1299 cells could
support productive IBV infection. As the initial virus stocks were
prepared by freezing and thawing IBV-infected Vero cells, most
infectious virus particles may be still associated with cellular
membranes and cell debris from Vero cells. The presence of
certain amounts of host enhancement factor(s) in these initial
virus stocks may help to establish efﬁcient infection during initial
propagation of IBV in the less permissive cell lines. In fact, much
less infection was observed in some of these cells when clariﬁed
virus stocks harvested from the culture media of IBV-infected
Vero cells were used (data not shown), supporting the argumentthat cellular membranes and cell debris from Vero cells contained
in the initial virus stocks may enhance IBV-infection of these less
permissive cell lines during passage 1.
In this study, a membrane-bound cellular proprotein conver-
tase, furin, is identiﬁed as a host cell factor that may enhance the
productive IBV infection in cultured cells. Among the ﬁve cell
lines tested in this study, Huh7 cells have the highest furin
expression level, followed by H1299 cells. Both cell lines could
support efﬁcient virus replication and productive infection. HeLa
cells, with an intermediate level of furin expression, were shown
to be susceptible to IBV infection under certain circumstances
(Chen et al., 2007), consistent with the observation in this study
that a certain level of furin-mediated cleavage of S protein was
observed in IBV-infected HeLa cells. Under the experimental
conditions used in this study, this cell line could support produc-
tive IBV infection up to passage 4. The other two cell lines, A549
and 293T, have the lowest furin expression level and can be
efﬁciently infected in passage 1 only; the infectivity dropped to
almost undetectable levels in passage 2. It was noted that quite
efﬁcient infection occurs in 293T cells in passage 1, probably
because 293T cells grow fast and tend to form large cell clumps as
well as more compact lawns, which may facilitate coronavirus
infection (Snijder et al., 2009). Nevertheless, the facts that cellular
furin content is nicely correlated with viral infectivity and
productive IBV infection in these ﬁve human cell lines and that
knockdown of furin by siRNA in H1299 aborts productive IBV
infection provide solid evidence supporting the conclusion that
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productive IBV infection. The less consistent observations gener-
ated from G418-resistant furin-knockin A549 cell clones infected
with IBV, on the other hand, point to the possibility that addi-
tional cellular factors are also involved in this process. In fact, it
was recently reported that several cellular factors are actively
involved in the IBV replication cycle. These include DDX1, MADP1
(zinc ﬁnger CCHC-type and RNA binding motif 1) and DNA
polymerase delta (Tan et al., 2012; Xu et al., 2010, 2011). It is
yet to be determined if the variation in the cellular contents of
these proteins may also contribute to the replication efﬁciency of
IBV in individual cell lines.
The furin-mediated enhancement effect on productive IBV
infection would be realized either by acceleration of viral spread
during primary infection or by promoting entry of the viruses
released from the primary infection in the same passage. The
exact role of furin in enhancement of cell permissiveness to IBV
infection is less clear. As furin-mediated cleavage of S protein at
the second furin site was shown to play an important role in viral
infectivity by promoting virus–cell and cell–cell fusion (Yamada
and Liu, 2009), it would be reasonable to speculate that furin may
facilitate viral entry and spread. In this regard, subtle differences
in expression of furin in different tissues and cells may explain
why IBV infects one tissue but not another, although it is believed
that furin is ubiquitously expressed (Bosshart et al., 1994; Molloy
et al., 1994). Further studies of the furin expression and distribu-
tion patterns in chicken and utilization of recombinant IBV
containing sequences from different pathogenic IBV strains would
provide more insights into IBV pathogenesis and cell and tissue
tropisms.Materials and methods
Viruses and cell lines
The Beaudette strain of IBV was purchased from ATCC and
propagated in chicken embryonated eggs for three passages. The
viruses were then adapted to grow and passage on Vero cells for
65 passages at 37 1C and used to infect other cell lines (Shen et al.,
2003; Liu et al., 1995).
A549 (ATCC CCL-185), BHK-21 (ATCC CCL-10), CHO (ATCC CCL-
61), HeLa (ATCC CCL-2), HepG2 (ATCC HB-8065), Hep3B (ATCC
HB-8064), Huh-7 (JCRB0403), 293T (ATCC, CRL-11268) and Vero
(ATCC CCL-81) cells were maintained in complete DMEMmedium
(JRH) supplemented with 10% newborn calf serum. Cos-7 (ATCC
CRL-1651), H1299 (ATCC CRL-5803), DLD-1 (ATCC CCL-221), DLD-
1 clone A (DLD-1A) and U-937 (ATCC CRL-1593.2) cells were
maintained in complete RPMI 1640 medium (JRH) supplemented
with 10% newborn calf serum. HCT116 (ATCC CCL-247) cells were
maintained in complete McCoy’s 5a medium (Sigma) supplemen-
ted with 10% newborn calf serum.Plaque puriﬁcation of virus
Viral stocks were 10-fold serially diluted and 200 ml of the
diluted virus stocks were added dropwise to the monolayer of
cells grown on 6-well plates with gentle swirling. Viruses were
allowed to infect cells for 2 h at 37 1C, 5% humidiﬁed CO2, with
occasional shaking. After the inoculum was removed, the cells
were washed twice with 1  PBS, and the monolayers were
overlaid with 1.5 ml DMEM containing 1% cell-culture grade, low
temperature melting agarose. The plates were left at room
temperature for about 15 min and then incubated at 37 1C, 5%
humidiﬁed CO2 for 4–7 day until the plaques were grown up.Individual plaques were selected and inoculated to fresh cell
monolayers for ampliﬁcation.
Western blot analysis
After SDS–PAGE, proteins were transferred to nitrocellulose
membrane (Bio-Rad) with a semidry transfer cell (Bio-Rad Trans
Blot SD). The membrane was blocked overnight at 4 1C in blocking
buffer containing 5% non-fat milk in TBST (20 mM Tris-HCl, pH
7.4, 150 mM NaCl, 0.1% Tween-20), incubated with speciﬁc
antiserum diluted in blocking buffer (1:500–1:2000) at room
temperature for 2 h, washed three times with TBST, and incu-
bated with horseradish peroxidase-conjugated anti-rabbit or anti-
mouse immunoglobulin (DAKO) diluted in blocking buffer
(1:2000) at room temperature for 1 h. Proteins were detected
using the enhanced chemiluminescence (ECL) detection reagents
(Amersham, UK).
Growth curve of IBV on Vero cells
Cells were infected with the Vero-adapted IBV, and harvested
at different time points post-infection. Virus stocks were prepared
by freezing/thawing of the infected cells three times. The 50%
tissue culture infection dose (TCID50) of each sample was
determined, as previously described, by infecting ﬁve wells of
Vero cells on 96-well plates in duplicate with 10-fold serial
dilution of each virus stock (Xu et al., 2010).
Immunoﬂuorescent (IF) staining
Cells were cultivated in 24-well plates and infected with IBV.
The infected cells were washed with phosphate buffered saline
(PBS) supplemented with 10% goat serum, ﬁxed with 4% paraf-
ormaldehyde in PBS for 15 min, and permeabilized with 0.2%
Triton X-100 for 10 min. IF staining was performed by incubating
cells with anti-IBV S antibodies and subsequently with the FITC-
conjugated anti-rabbit IgG. Cells were examined by ﬂuorescent
microscopy.
RNA interference and selection of stable cells with knockin or
knockdown of a gene
Cells with 60% conﬂuence were grown on 6-well plates and
transfected with 20 nM of siRNA duplexes targeting either furin
(50–GGACUAAACGGGACGUGUA-30) or EGFP (50–GCAACGUGACC-
CUGAAGUUC-3) with LipofectamineTM RNAiMAX (Invitrogen). At
24 h post-transfection, cells were infected with IBV at a multi-
plicity of infection of approximately 2.
The furin coding region was ampliﬁed by RT-PCR, and the PCR
fragment was cloned into a mammalian expression vector with a
neomycin selection marker, and transfected into cells. At 24 h
post-transfection, 1 mg/ml of G418 was added to the medium. At
a 3-day interval, the medium was replaced with fresh medium
containing the same concentration of G418. G418-resistant clones
were picked approximately 30 day later and ampliﬁed. The
ampliﬁed cell clones were harvested and analyzed by Northern
and Western blot analyses. Clones with different levels of furin
expression were selected for subsequent studies.
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